Lanzamiento Enero 2027

Ensayo controlado aleatorizado2024Financiación no declaradaSolo mecanismos

Added γ-oryzanol boosted anti-inflammatory effects of canola oil in adult subjects with type 2 diabetes: a randomized controlled clinical trial

Nikooyeh B, Zargaraan A, Ebrahimof S, Kalayi A, Zahedirad M, Yazdani H, Rismanchi M, Karami T, Khazraei M, Jafarpour A, Neyestani TR

European journal of nutrition · 0 citas

Etiquetas de revisión

Financiación no declaradaSolo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Solo mecanismos
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2023-11-16 · Eur J Nutr · vol. 63 · número 2 · págs. 425–433
Editorial
Springer Science+Business Media
Citado
6 citas · más que el 72% de estudios similares · 0.9× el promedio de su campo
Referencias
52 trabajos
Acceso
De pago
Áreas de investigación
Fatty Acid Research and Health · Adipokines, Inflammation, and Metabolic Diseases · Antioxidant Activity and Oxidative Stress
Palabras clave
γ-oryzanol, canola oil, type 2 diabetes, anti-inflammatory activity, oxidative stress, inflammatory markers, sunflower oil, high-sensitivity C-reactive protein, interleukin-6, IL-1β, interferon-gamma, salivary IgA, malondialdehyde, food fortification
MeSH
humans, diabetes mellitus, type 2, phenylpropionates, anti-inflammatory agents, adult, female, male, sunflower oil, rapeseed oil

11 autores

  • Bahareh‎ Nikooyeh🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Azizollaah Zargaraan🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Samira Ebrahimof🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Ali Kalayi🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Maliheh Zahedirad🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Hootan Yazdani🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Marjan Rismanchi🇮🇷National Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Taher Karami
  • Marzieh Khazraei
  • Ali Jafarpour
  • Tirang Reza Neyestani🇮🇷 · autor de correspondenciaNational Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

This study was conducted to examine the effects of daily intake of γ-oryzanol (ORZ)-fortified canola oil, as compared with plain canola and sunflower oils, on certain inflammatory and oxidative stress biomarkers in adult subjects with Type 2 Diabetes (T2D).

Methods

We randomly allocated 92 adult subjects with T2D from both sexes to one of the following groups to receive: (a) ORZ-fortified canola oil (ORZO; n1 = 30); (b) unfortified canola oil (CANO; n2 = 32); or (c) sunflower oil (SUFO; n3 = 30) for 12 weeks. Dietary and laboratory evaluations were performed initially and finally.

Results

Serum hs-CRP concentrations significantly decreased in ORZO group (from 3.1 ± 0.2 to 1.2 ± 0.2 mg/L), as compared with CANO (p = 0.003) and SUFO (p < 0.001) groups. Serum IL-6 significantly decreased just in ORZO (- 22.8%, p = 0.042) and CANO groups (- 19.8%, p = 0.038). However, the between-group differences were not significant. Serum IL-1β slightly decreased in ORZO (- 28.1%, p = 0.11) and increased in SUFO (+ 20.6%, p = 0.079) but between-group difference was statistically significant (p = 0.017). Serum IFN-γ concentrations decreased significantly only in ORZO (from 3.3 ± 0.08 to 2.9 ± 0.21 IU/mL, p = 0.044). Salivary IgA concentrations increased significantly in all three intervention groups. Notwithstanding, only the difference between ORZO and CANO groups was statistically significant (p = 0.042). Similarly, circulating malondialdehyde concentrations significantly decreased in all three groups but with no between-group significant difference.

Conclusions

Daily consumption of ORZ-fortified canola oil, compared with unfortified canola and sunflower oils, for 12 weeks resulted in boosting of certain anti-inflammatory effects of canola oil. These findings may have preventive implications for both clinicians and policy makers. This clinical trial was registered at clinicaltrials.gov (03.08.2022; NCT05271045).

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.